| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.49 | 0.002 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.094 | 0.003 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.16 | 0.003 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.003 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | 0.46 | 0.004 |